Report Detail
Global (United States, European Union and China) Psoriasis Drug Market Research Report 2019-2025
- RnM3689604 |
- 22 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Psoriasis is a long-lasting autoimmune disease which is characterized by patches of abnormal skin.
In 2019, the market size of Psoriasis Drug is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Psoriasis Drug.
This report studies the global market size of Psoriasis Drug, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Psoriasis Drug sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AbbVie
Johnson & Johnson
Bayer
Galderma
Bristol-Myers Squibb
Novartis
Pfizer
Merz Pharma
Valeant
LEO Pharma
GlaxoSmithKline
Market Segment by Product Type
External Use
Oral
Injection
Market Segment by Application
Hospital
Drugs Store
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Psoriasis Drug status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Psoriasis Drug manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Psoriasis Drug are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Psoriasis Drug Market Size Growth Rate by Type (2019-2025)
- 1.3.2 External Use
- 1.3.3 Oral
- 1.3.4 Injection
- 1.4 Market Segment by Application
- 1.4.1 Global Psoriasis Drug Market Share by Application (2019-2025)
- 1.4.2 Hospital
- 1.4.3 Drugs Store
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Psoriasis Drug Market Size
- 2.1.1 Global Psoriasis Drug Revenue 2014-2025
- 2.1.2 Global Psoriasis Drug Sales 2014-2025
- 2.2 Psoriasis Drug Growth Rate by Regions
- 2.2.1 Global Psoriasis Drug Sales by Regions 2014-2019
- 2.2.2 Global Psoriasis Drug Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Psoriasis Drug Sales by Manufacturers
- 3.1.1 Psoriasis Drug Sales by Manufacturers 2014-2019
- 3.1.2 Psoriasis Drug Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Psoriasis Drug Revenue by Manufacturers (2014-2019)
- 3.2.2 Psoriasis Drug Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Psoriasis Drug Market Concentration Ratio (CR5 and HHI)
- 3.3 Psoriasis Drug Price by Manufacturers
- 3.4 Key Manufacturers Psoriasis Drug Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Psoriasis Drug Market
- 3.6 Key Manufacturers Psoriasis Drug Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 External Use Sales and Revenue (2014-2019)
- 4.1.2 Oral Sales and Revenue (2014-2019)
- 4.1.3 Injection Sales and Revenue (2014-2019)
- 4.2 Global Psoriasis Drug Sales Market Share by Type
- 4.3 Global Psoriasis Drug Revenue Market Share by Type
- 4.4 Psoriasis Drug Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Psoriasis Drug Sales by Application
6 United States
- 6.1 United States Psoriasis Drug Breakdown Data by Company
- 6.2 United States Psoriasis Drug Breakdown Data by Type
- 6.3 United States Psoriasis Drug Breakdown Data by Application
7 European Union
- 7.1 European Union Psoriasis Drug Breakdown Data by Company
- 7.2 European Union Psoriasis Drug Breakdown Data by Type
- 7.3 European Union Psoriasis Drug Breakdown Data by Application
8 China
- 8.1 China Psoriasis Drug Breakdown Data by Company
- 8.2 China Psoriasis Drug Breakdown Data by Type
- 8.3 China Psoriasis Drug Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Psoriasis Drug Breakdown Data by Company
- 9.2 Rest of World Psoriasis Drug Breakdown Data by Type
- 9.3 Rest of World Psoriasis Drug Breakdown Data by Application
- 9.4 Rest of World Psoriasis Drug Breakdown Data by Countries
- 9.4.1 Rest of World Psoriasis Drug Sales by Countries
- 9.4.2 Rest of World Psoriasis Drug Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AbbVie
- 10.1.1 AbbVie Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.1.4 Psoriasis Drug Product Introduction
- 10.1.5 AbbVie Recent Development
- 10.2 Johnson & Johnson
- 10.2.1 Johnson & Johnson Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.2.4 Psoriasis Drug Product Introduction
- 10.2.5 Johnson & Johnson Recent Development
- 10.3 Bayer
- 10.3.1 Bayer Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.3.4 Psoriasis Drug Product Introduction
- 10.3.5 Bayer Recent Development
- 10.4 Galderma
- 10.4.1 Galderma Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.4.4 Psoriasis Drug Product Introduction
- 10.4.5 Galderma Recent Development
- 10.5 Bristol-Myers Squibb
- 10.5.1 Bristol-Myers Squibb Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.5.4 Psoriasis Drug Product Introduction
- 10.5.5 Bristol-Myers Squibb Recent Development
- 10.6 Novartis
- 10.6.1 Novartis Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.6.4 Psoriasis Drug Product Introduction
- 10.6.5 Novartis Recent Development
- 10.7 Pfizer
- 10.7.1 Pfizer Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.7.4 Psoriasis Drug Product Introduction
- 10.7.5 Pfizer Recent Development
- 10.8 Merz Pharma
- 10.8.1 Merz Pharma Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.8.4 Psoriasis Drug Product Introduction
- 10.8.5 Merz Pharma Recent Development
- 10.9 Valeant
- 10.9.1 Valeant Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.9.4 Psoriasis Drug Product Introduction
- 10.9.5 Valeant Recent Development
- 10.10 LEO Pharma
- 10.10.1 LEO Pharma Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Psoriasis Drug
- 10.10.4 Psoriasis Drug Product Introduction
- 10.10.5 LEO Pharma Recent Development
- 10.11 GlaxoSmithKline
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Psoriasis Drug Sales Channels
- 11.2.2 Psoriasis Drug Distributors
- 11.3 Psoriasis Drug Customers
12 Market Forecast
- 12.1 Global Psoriasis Drug Sales and Revenue Forecast 2019-2025
- 12.2 Global Psoriasis Drug Sales Forecast by Type
- 12.3 Global Psoriasis Drug Sales Forecast by Application
- 12.4 Psoriasis Drug Forecast by Regions
- 12.4.1 Global Psoriasis Drug Sales Forecast by Regions 2019-2025
- 12.4.2 Global Psoriasis Drug Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Psoriasis Drug. Industry analysis & Market Report on Psoriasis Drug is a syndicated market report, published as Global (United States, European Union and China) Psoriasis Drug Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Psoriasis Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
